Guobang Pharma Ltd Capital Reinvestment Ratio
Guobang Pharma Ltd capital reinvestment ratio. Guobang Pharma Ltd (605507) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥311.27 Million) in capital expenditures (CN¥110.58 Million). Check Guobang Pharma Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guobang Pharma Ltd (2017–2025)
Capital reinvestment ratio of Guobang Pharma Ltd from 2017 to 2025. This chart tracks Guobang Pharma Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore 605507 net asset momentum to track the company's year-over-year net asset growth rate.
Guobang Pharma Ltd Capital Reinvestment Ratio by Year (2017–2025)
Guobang Pharma Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Guobang Pharma Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | CN¥559.28 Million | CN¥277.71 Million | ▼ -16.3% |
| 2024 | 0.59x | CN¥706.41 Million | CN¥419.12 Million | ▼ -59.0% |
| 2023 | 1.45x | CN¥516.76 Million | CN¥748.44 Million | ▲ +83.4% |
| 2022 | 0.79x | CN¥1.02 Billion | CN¥803.12 Million | ▲ +16.5% |
| 2020 | 0.68x | CN¥767.70 Million | CN¥520.16 Million | ▼ -50.6% |
| 2019 | 1.37x | CN¥440.86 Million | CN¥605.18 Million | ▲ +355.5% |
| 2018 | 0.30x | CN¥541.68 Million | CN¥163.24 Million | ▼ -73.7% |
| 2017 | 1.14x | CN¥148.03 Million | CN¥169.48 Million | — |